ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
Top holders
| Fund | Weight (%) | Value |
|---|---|---|
| AGTHXAmerican Funds Growth Fund of America Class A | 0.6 | $2.32B |
| VTIVanguard Morningstar Total Stock Market ETF | 0.1 | $1.28B |
| AMCPXAmerican Funds AMCAP Fund Class A | 1.3 | $1.24B |
| VOVanguard Morningstar Mid-Cap ETF | 0.4 | $871M |
| QQQInvesco QQQ Trust | 0.2 | $853M |
| PRWCXT. Rowe Price Capital Appreciation Fund | 0.9 | $613M |
| VUGVanguard Morningstar Growth ETF | 0.1 | $489M |
| AICCXInvestment Co of America Class C | 0.3 | $486M |
| VXFVanguard Extended Market ETF | 0.5 | $461M |
| FOCPXFidelity OTC Portfolio | 1.0 | $440M |
Holders
- Funds
- 255
- Held in all
- $18.6B
- Held by the top 10
- 48.6%
- Highest weight
- BBH3.8%